Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp

doi:10.5306/wjco.v8.i5.405

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8775)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

406

WORD

254

HTML

3116

Figures (1-2)

332

Tables (1-4)

274

Sum=4382

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

834

Download

1497

Sum=2331

Publishing Process of This Article

Item

Count

Browse

666

Download

1396

Sum=2062

Oct 10, 2017 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Oct 10, 2017; 8(5): 405-411
Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.405

Full Size Figure Download Figure

$[Label] $[Caption_0] $[Caption_1]

Citation: Skroza N, Proietti I, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Tolino E, Zuber S, La Torre G, Potenza C. Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp. World J Clin Oncol 2017; 8(5): 405-411
URL: https://www.wjgnet.com/2218-4333/full/v8/i5/405.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i5.405